A detailed history of Federated Hermes, Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 3 shares of OCUL stock, worth $27. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 1 200.0%
Holding current value
$27
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.45 - $9.23 $12 - $18
2 Added 200.0%
3 $0
Q2 2024

Aug 08, 2024

SELL
$4.2 - $8.69 $247 - $512
-59 Reduced 98.33%
1 $0
Q1 2024

May 14, 2024

BUY
$3.85 - $10.93 $231 - $655
60 New
60 $0
Q2 2023

Aug 14, 2023

BUY
$4.6 - $7.64 $11,624 - $19,306
2,527 Added 1148.64%
2,747 $14,000
Q1 2023

May 08, 2023

SELL
$2.79 - $6.27 $393 - $884
-141 Reduced 39.06%
220 $1,000
Q4 2022

Feb 13, 2023

SELL
$2.61 - $4.41 $2.09 Million - $3.53 Million
-801,375 Reduced 99.95%
361 $1,000
Q3 2022

Nov 14, 2022

SELL
$4.09 - $6.5 $1.6 Million - $2.54 Million
-390,336 Reduced 32.74%
801,736 $3.33 Million
Q2 2022

Aug 15, 2022

BUY
$3.01 - $5.22 $1.72 Million - $2.97 Million
569,792 Added 91.57%
1,192,072 $4.79 Million
Q1 2022

May 13, 2022

BUY
$4.83 - $7.35 $3.01 Million - $4.57 Million
622,280 New
622,280 $3.08 Million
Q2 2021

Aug 16, 2021

SELL
$13.43 - $19.16 $4.21 Million - $6 Million
-313,238 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$15.82 - $22.11 $1.02 Million - $1.42 Million
64,327 Added 25.84%
313,238 $5.14 Million
Q4 2020

Feb 12, 2021

BUY
$7.91 - $22.95 $1.97 Million - $5.71 Million
248,702 Added 118996.17%
248,911 $5.15 Million
Q3 2020

Nov 12, 2020

BUY
$7.36 - $9.87 $1,538 - $2,062
209 New
209 $2,000
Q2 2018

Aug 10, 2018

SELL
$5.99 - $8.17 $65 - $89
-11 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$4.66 - $7.08 $512 - $778
-110 Reduced 90.91%
11 $1,000
Q3 2017

Nov 13, 2017

BUY
$5.28 - $6.88 $638 - $832
121
121 $1,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $694M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.